Charles Deignan

Insider Reports History

Location
Alpharetta, GA
Signature
/s/ Charles Deignan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Deignan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Clearside Biomedical, Inc. Chief Financial Officer Common Stock 384,662 $488,521 $1.27 19 Jan 2024 Direct
Clearside Biomedical, Inc. Chief Financial Officer Employee Stock Option (right to buy) 200,000 08 Jan 2025 Direct
Clearside Biomedical, Inc. Chief Financial Officer Employee Stock Option (right to buy) 200,000 18 Jan 2024 Direct

Insider Reports Filed by Charles Deignan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CLSD Clearside Biomedical, Inc. 08 Jan 2025 1 $0 4 Chief Financial Officer 10 Jan 2025, 16:30
CLSD Clearside Biomedical, Inc. 18 Jan 2024 2 -$16,512 4 Chief Financial Officer 19 Jan 2024, 18:25
CLSD Clearside Biomedical, Inc. 18 Sep 2023 1 $0 4 Chief Financial Officer 20 Sep 2023, 17:30
CLSD Clearside Biomedical, Inc. 13 Sep 2023 2 +$13,636 4 Chief Financial Officer 13 Sep 2023, 19:55
CLSD Clearside Biomedical, Inc. 19 Jan 2023 1 -$21,045 4 Chief Financial Officer 20 Jan 2023, 15:29
CLSD Clearside Biomedical, Inc. 04 Jan 2023 1 $0 4 Chief Financial Officer 06 Jan 2023, 15:28
CLSD Clearside Biomedical, Inc. 20 Dec 2022 2 +$9,454 4 Chief Financial Officer 20 Dec 2022, 15:38
CLSD Clearside Biomedical, Inc. 18 Jan 2022 2 $0 4/A Chief Financial Officer 28 Jan 2022, 15:51
CLSD Clearside Biomedical, Inc. 21 Sep 2021 1 -$17,948 4 Chief Financial Officer 23 Sep 2021, 17:12
CLSD Clearside Biomedical, Inc. 21 Jun 2021 1 -$12,839 4 Chief Financial Officer 23 Jun 2021, 17:42